CELINA SANCHEZ, PA: Open Payments
NPI 1336871110 · PHARR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $103 |
| Amgen Inc. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: Rybelsus, XIFAXAN, REXULTI, JARDIANCE, VOQUEZNA, KRYSTEXXA, Ozempic, SHINGRIX.
Industry payments across TX — which companies pay providers there.
